Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality

Background Identification of lifestyle modifiable metabolic pathways related to cardiometabolic disease risk is essential for improvement of primary prevention in susceptible individuals. It was recently shown that plasma dimethylguanidino valerate (DMGV) levels are associated with incident type 2 d...

Full description

Bibliographic Details
Main Authors: Filip Ottosson, Ulrika Ericson, Peter Almgren, Einar Smith, Louise Brunkwall, Sophie Hellstrand, Peter M. Nilsson, Marju Orho‐Melander, Céline Fernandez, Olle Melander
Format: Article
Language:English
Published: Wiley 2019-10-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.012846